New wrinkle treatment takes on botox in major trial
NCT ID NCT06585696
First seen Feb 01, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tested a new injection called CU-20101 for treating moderate to severe frown lines between the eyebrows. It involved 554 adults aged 18 to 65 and compared CU-20101 to the well-known treatment Botox. The goal was to see if CU-20101 works as well and is safe, both after a single use and with repeated treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLABELLAR FROWN LINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 200443, China
Conditions
Explore the condition pages connected to this study.